Overview

This trial is active, not recruiting.

Condition depression
Treatment care management
Sponsor National Clinical Research Coordination Center, Seoul, Korea
Start date March 2013
End date December 2016
Trial size 100 participants
Trial identifier NCT01817244, A102065_2013

Summary

Suicide is a significant cause of death in Korea. According to the report compiled by the Korea National Statistical Office, 24.8 victims of every 100,000 in 2007 (Korea National Statistical Office, 2008), which is higher compared with 10.1 in the United States, 6.0 in the United Kingdom, and 19.1 in Japan (Organisation for Economic Co-operation and Development, 2008). Especially, suicide rate is incredibly higher in elderly. Most persons who commit suicide have a diagnosed psychiatric disorder. Among them, 60% had Depression when they committed suicide. Therefore, this study aimed the impact of a care management intervention on depression treatment and reducing suicidal ideation in elderly patients with depression.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (subject, investigator, outcomes assessor)
Primary purpose treatment
Arm
(Experimental)
2-month care management
care management
6-month care management
(Active Comparator)
6-month care management
care management
6-month care management

Primary Outcomes

Measure
Hamilton Depression Scale (HAMD)
time frame: 6 months after baseline

Secondary Outcomes

Measure
suicide ideation
time frame: 6 months after baseline
treatment compliance
time frame: at 6 months from baseline

Eligibility Criteria

Male or female participants at least 60 years old.

Inclusion Criteria: - 60 and older - current major or minor depression Exclusion Criteria: - severe cognitive dysfunction - severe auditory dysfunction - history of psychosis

Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by National Clinical Research Coordination Center, Seoul, Korea.